The SEE-CITE platform, developed at UCLA, accurately maps known protein interaction sites of two FDA-approved cancer drugs (in red and blue).
Credit
CNSI at UCLA
Usage Restrictions
none
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.